A Comparison of Cyclophosphamide, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone in Transplant Eligible Patients with Newly Diagnosed Multiple Myeloma

被引：0

作者：

Figueiredo, Amarilis ^{[1
]}

Atkins, Harold ^{[1
,2
,3
,4
]}

Mallick, Ranjeeta ^{[5
,6
]}

Kekre, Natasha ^{[1
,2
,3
,4
]}

Kew, Andrea ^{[2
,3
,4
]}

McCurdy, Arleigh ^{[1
,3
,4
]}

机构：

[1] Ottawa Hosp Res Inst, Ottawa, ON, Canada

[2] Ottawa Hosp, Div Hematol, Ottawa, ON, Canada

[3] Ottawa Hosp, Dept Med, Ottawa, ON, Canada

[4] Univ Ottawa, Ottawa, ON, Canada

[5] Univ Ottawa, Sch Epidemiol, Publ Hlth & Prevent Med, Ottawa, ON, Canada

[6] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada

来源：

关键词：

D O I：

10.1182/blood.V128.22.4519.4519

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

4519

引用

页数：5